Corcept Therapeutics Research and Development Expenses 2010-2024 | CORT
Corcept Therapeutics research and development expenses for the twelve months ending September 30, 2024 were $0.231B, a 39% increase year-over-year.
- Corcept Therapeutics annual research and development expenses for 2023 were $0.184B, a 40.74% increase from 2022.
- Corcept Therapeutics annual research and development expenses for 2022 were $0.131B, a 15.04% increase from 2021.
- Corcept Therapeutics annual research and development expenses for 2021 were $0.114B, a 0.78% decline from 2020.